Cingulate Inc. (CING)

NASDAQ

$4.88

$+0.04

(+0.93%)

Pre-Market

Cingulate Inc. (CING) Live Price Chart

Last updated: ⁦2026-10-13 12:30:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Cingulate Inc. (CING) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $4.88, with a market capitalisation of $71.11M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $3.16 to $11.89. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$71.11M
Open	$4.84
Day's High	$1,236.00
Day's Low	$1.80
Previous Close	$4.84
Volume	579.00
Average Volume	127.57K
P/E Ratio	--
52-Week High	$11.89
52-Week Low	$3.16
Dividend Yield	--
Earnings Date	--

Cingulate Inc. (CING) Pre-Market Stock Price

Cingulate Inc. (CING) is trading at $4.88 in pre-market trading as of 2026-10-13 11:50:00, up 0.83% ($0.04) from the previous close of $4.84

Pre-market trading shows how investors are pricing CING before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Cingulate Inc. (CING) 7-Day Stock Price Change

Over the past seven days, Cingulate Inc. (CING) moved from $4.76 to $4.88, representing a gain of 2.52% ($0.12).

The stock traded between $4.45 and $5.00 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 79.09 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

CING 52-Week Price Position

Position in Range: 19.7%

52W Low$3.16

52W High$11.89

CING is currently trading at $4.88, placing it 19.7% of the way from its 52-week low of $3.16 to its 52-week high of $11.89. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Cingulate Inc. (CING)?

Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

Cingulate Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	14
Exchange	NASDAQ
Company Website	https://www.cingulate.com

How to Buy Cingulate Inc. (CING) Stock on MEXC

Eligible investors can buy real shares of Cingulate Inc. (CING) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for CING and Place Your Order

Open the RealStocks trading page and search for CING. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Cingulate Inc. (CING) stock price today?

Cingulate Inc. (CING) is currently trading at $ 4.88, up 0.83% ($0.04) from the previous close of $ 4.84. Intraday prices update in real time during regular trading hours.

2.Is CING stock going up or down today?

As of 2026-10-13 11:50:00, CING is trading at $ 4.88, up 0.83% ($0.04) from its previous close of $ 4.84. The stock has traded between $ 1.80 and $ 1,236.00 during today’s regular session. Past price movements do not guarantee future results.

3.What is CING pre-market price?

As of 2026-10-13 11:50:00, CING is trading at $ 4.88 in pre-market trading, up 0.83% ($0.04) from the previous close of $ 4.84. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is CING after-hours price?

As of 2026-10-13 11:50:00, CING is trading at $ 4.84 in after-hours trading, down 0.10% ($0.00) from the regular-session close of $ 4.84. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is CING stock trading now?

CING trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does CING sit relative to its 52-week high and low?

Over the past 52 weeks, CING has traded between a low of $ 3.16 and a high of $ 11.89. At $ 4.88, the stock is positioned 19.7% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Cingulate Inc. in?

Cingulate Inc. (CING) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Cingulate Inc.'s market capitalisation and where is it listed?

Cingulate Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 71.11M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is CING valued in terms of P/E ratio and EPS?

CING trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -1.98. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Cingulate Inc. pay a dividend?

Cingulate Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.